[1] Webb BC,Thomas CJ,Willcox MD,et al.Candida-associated denture stomatitis.Aetiology and management:a review.Part 3.Treatment of oral candidosis[J].Aust Dent J,1998,43 (4):244-249.
[2] Liu X,Liu H,Guo Z,et al.Association of asymptomatic oral Candida carriage,oral candidiasis and CD4 lymphocyte count in HIV-pesitive patients in China[J].Oral Dis,2006,12(1):41-44.
[3] Worthington HV,Eden OB,Clarkson JE.Interventions for preventing oral candidiasis for patients with cancer receiving treatment[J].The Cochrane Library,Issue 2,2006.
[4] Lass-Flori C,Gunsilius E,Gastl G,et al.Fungal colonization in neutropenic patients:a randomised study comparing itraconazole solution and amphotericin B solution[J].Ann Hematol,2003,82(9):565-569.
[5] Hoppe J,Burr R,Ebeling H,et al.Treatment of oropharyngeal candidiasis in immnunocompetent infants:a randomized multicenter study of miconazole gel vs.nystatin suspension[J].Pediatr Infect Dis J,1997,16(3):288-293.
[6] Hoppe JE,Hahn H.Randomized comparison of two nystatin oral gels with miconazole oral gel for treatment of oral thrush in infants.Antimycotics Study Group[J].Infection,1996,24(2):136-139.
[7] Goins RA,Ascher D,Waecker N,et al.Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants[J].Pediatr Infect Dis J,2002,21 (12):1165-1167.
[8] Flynn PM,Cunningham CK,Kerkering T,et al.Oropharyngeal candidiasis in immunocompromised children:a randomized,multicenter study of orally administered fluconazole suspension versus nyststin.The multicenter fluconazole study group[J].J Pediatr,1995,127(2):322-328.
[9] Ninane JA.Multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies.Multicentre study group[J].Eur J Clin Microbiol Infect Dis,1994,13(4):330-337.
[10] Groll AH,Just-Nuebling G,Kurz M,et al.Fluconazole versus nystatin in the prevention of Candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer[J].J Antimicrob Chemother,1997,40(6):855-862.
[11] Koray M,Ak G,Kurklu E,et al.Fluconazole and/or hexetidine for management of oral candidinsis associated with dentureinduced stomatitis[J].Oral Dis,2005,11 (5):309-313.
[12] Vasconcelos LC,Sampaio MC,Sampaio FC,et al.Use of Punica granatum as an antifungal agent against candidosis associated with denture stomatitis[J].Mycoses,2003,46 (5-6):192-196.
[13] De Punzio C,Garutti P,Mollica M,et al.Fluconazole 150mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis:a double-blind randomized study[J].Eur JObs Gynecol Reprod Biol,2003,106(2):193-197.
[14] Stein GE,Munmaw N.Placebo-controlled trial of itraconazole for treatment of acute vaginal candidinsis[J].Antimicrib Agents Chemother,1993,37(1):89-92.
[15] Van Kessel K,Assefi N,Marrazzo J,et al.Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis:a systematic review[J].Obstet Gynecol Surv,2003,58(5):351-358.
[16] Sobel JD,Wiesenfeld HC,Martens M,et al.Maintenance flucouazole therapy for recurrent vulvovaginal candidiasis[J].N Engl J Med,2004,351 (9):876-883.
[17] SpinilloA,ColonnaL,PiazziG,et al.Managing recurrent vulvovaginal candidiasis.Intermittent prevention with itraconazole[J].J Reprod Med,1997,42(2):83-87.
[18] Fong IW.The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis[J].Genitourin Med,1992,68 (6):374-377. |
